Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Design Therapeutics (DSGN) Equity Ratio (2020 - 2026)

Design Therapeutics' Equity Ratio history spans 2 years, with the latest figure at 0.98 for Q4 2021.

  • On a quarterly basis, Equity Ratio rose 415.76% to 0.98 in Q4 2021 year-over-year; TTM through Dec 2021 was 0.98, a 415.76% increase, with the full-year FY2021 number at 0.98, up 415.76% from a year prior.
  • Equity Ratio hit 0.98 in Q4 2021 for Design Therapeutics, roughly flat from 0.98 in the prior quarter.
  • Over the last five years, Equity Ratio for DSGN hit a ceiling of 0.99 in Q2 2021 and a floor of 0.31 in Q4 2020.